Singulair (montelukast) for asthma

March 1998

Merck is introducing Singulair (montelukast) for asthma.

It's a new leukotriene antagonist...in the same class as Accolate (zafirlukast). It's a little different than Zyflo.

Singulair and Accolate block the ACTION of leukotrienes in the lungs...Zyflo (zileuton) inhibits their PRODUCTION.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Homocysteine may be an important risk factor for heart disease and stroke
Cardiology Whether patients on warfarin can take acetaminophen
Cardiology Patients can still take erythromycin to prevent bacterial endocarditis
Neurology Pain Stronger warning about potential hepatotoxicity in patients taking Duract (bromfenac)
Obesity Weight Loss New obesity drug, Meridia
Singulair (montelukast) for asthma
Serevent (salmeterol), is now approved for chronic obstructive pulmonary disease (COPD)
Gastroenterology PrevPac for H. pylori
Neurology Pain Amerge (naratriptan) for migraines
Neurology Pain Some Parkinson's patients will be taking Tasmar (tolcapone)
Women s Health New strength of Prempro
Women s Health Topical testosterone for libido
Venastat, a new herbal product for leg swelling due to varicose veins
Pediatrics Childhood vaccine recommendations
Pediatrics Syrup of ipecac isn't used much anymore
Diabetes Not to prescribe metformin (Glucophage) to patients with congestive heart failure
Diabetes Diabetics on calcium blockers suffer more Mis